Intuitive Surgical, Inc. $ISRG Shares Sold by Clarius Group LLC

Key Points

• Clarius Group LLC reduced its stake in Intuitive Surgical by 37%, owning 1,282 shares valued at approximately $697,000 after selling 752 shares in the second quarter.
• Intuitive Surgical reported an earnings per share of $2.19 for the most recent quarter, exceeding analysts' expectations of $1.93, with revenue of $2.44 billion, representing a 21.4% year-over-year increase.
• The stock has a market capitalization of $162.16 billion, with institutional investors holding 83.64% of the shares, indicating strong confidence among major investors.

Clarius Group LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 37.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,282 shares of the medical equipment provider's stock after selling 752 shares during the quarter. Clarius Group LLC's holdings in Intuitive Surgical were worth $697,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of ISRG. Nuveen LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at about $1,715,899,000. Goldman Sachs Group Inc. grew its position in Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after acquiring an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after acquiring an additional 566,979 shares in the last quarter. Wellington Management Group LLP grew its position in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after buying an additional 453,335 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 2.1%

Shares of ISRG stock opened at $452.35 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a market cap of $162.16 billion, a P/E ratio of 63.09, a P/E/G ratio of 4.74 and a beta of 1.61. The business has a fifty day simple moving average of $463.55 and a 200-day simple moving average of $500.11.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter last year, the business posted $1.78 earnings per share. The business's revenue for the quarter was up 21.4% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. BTIG Research reissued a "buy" rating and set a $571.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 1st. Evercore ISI boosted their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Royal Bank Of Canada restated an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $594.19.

Insider Activity

In other news, Director Amy L. Ladd sold 336 shares of the firm's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.